This company has been marked as potentially delisted and may not be actively trading. Third Harmonic Bio (THRD) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock THRD vs. QURE, SION, CRMD, EYPT, FTRE, TRVI, ZBIO, PHAT, GERN, and IOVAShould you be buying Third Harmonic Bio stock or one of its competitors? The main competitors of Third Harmonic Bio include uniQure (QURE), Sionna Therapeutics (SION), CorMedix (CRMD), Eyepoint Pharmaceuticals (EYPT), Fortrea (FTRE), Trevi Therapeutics (TRVI), Zenas BioPharma (ZBIO), Phathom Pharmaceuticals (PHAT), Geron (GERN), and Iovance Biotherapeutics (IOVA). These companies are all part of the "med - biomed/gene" industry. Third Harmonic Bio vs. Its Competitors uniQure Sionna Therapeutics CorMedix Eyepoint Pharmaceuticals Fortrea Trevi Therapeutics Zenas BioPharma Phathom Pharmaceuticals Geron Iovance Biotherapeutics uniQure (NASDAQ:QURE) and Third Harmonic Bio (NASDAQ:THRD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. Which has preferable valuation and earnings, QURE or THRD? Third Harmonic Bio has lower revenue, but higher earnings than uniQure. Third Harmonic Bio is trading at a lower price-to-earnings ratio than uniQure, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiouniQure$27.12M29.28-$239.56M-$3.92-3.69Third Harmonic BioN/AN/A-$45.47M-$0.62-8.68 Does the media refer more to QURE or THRD? In the previous week, uniQure had 2 more articles in the media than Third Harmonic Bio. MarketBeat recorded 2 mentions for uniQure and 0 mentions for Third Harmonic Bio. uniQure's average media sentiment score of 0.95 beat Third Harmonic Bio's score of 0.00 indicating that uniQure is being referred to more favorably in the media. Company Overall Sentiment uniQure Positive Third Harmonic Bio Neutral Do analysts rate QURE or THRD? uniQure currently has a consensus target price of $37.45, indicating a potential upside of 158.84%. Third Harmonic Bio has a consensus target price of $5.00, indicating a potential downside of 7.06%. Given uniQure's stronger consensus rating and higher possible upside, research analysts plainly believe uniQure is more favorable than Third Harmonic Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score uniQure 0 Sell rating(s) 2 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.00Third Harmonic Bio 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is QURE or THRD more profitable? Third Harmonic Bio has a net margin of 0.00% compared to uniQure's net margin of -1,387.98%. Third Harmonic Bio's return on equity of -19.27% beat uniQure's return on equity.Company Net Margins Return on Equity Return on Assets uniQure-1,387.98% -1,010.74% -33.27% Third Harmonic Bio N/A -19.27%-18.67% Do institutionals and insiders have more ownership in QURE or THRD? 78.8% of uniQure shares are held by institutional investors. Comparatively, 94.0% of Third Harmonic Bio shares are held by institutional investors. 4.8% of uniQure shares are held by insiders. Comparatively, 7.8% of Third Harmonic Bio shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, QURE or THRD? uniQure has a beta of 0.13, meaning that its stock price is 87% less volatile than the S&P 500. Comparatively, Third Harmonic Bio has a beta of 2.12, meaning that its stock price is 112% more volatile than the S&P 500. SummaryuniQure and Third Harmonic Bio tied by winning 8 of the 16 factors compared between the two stocks. Get Third Harmonic Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for THRD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding THRD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart THRD vs. The Competition Export to ExcelMetricThird Harmonic BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$242.80M$3.09B$5.70B$10.27BDividend YieldN/A2.32%5.72%4.60%P/E Ratio-4.3721.3075.8626.51Price / SalesN/A380.87491.12165.50Price / CashN/A44.4425.8129.89Price / Book0.859.6112.846.32Net Income-$45.47M-$53.28M$3.28B$270.51M Third Harmonic Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)THRDThird Harmonic Bio0.1964 of 5 stars$5.38flat$5.00-7.1%N/A$242.80MN/A-4.37N/AQUREuniQure3.2761 of 5 stars$17.49+0.3%$37.45+114.1%+162.2%$956.33M$27.12M-4.46500SIONSionna Therapeutics2.8321 of 5 stars$24.50+13.3%$38.00+55.1%N/A$954.31MN/A0.0035Gap UpCRMDCorMedix3.9067 of 5 stars$13.03+2.2%$18.00+38.1%+82.0%$951.78M$43.47M17.3730Analyst UpgradeEYPTEyepoint Pharmaceuticals1.8269 of 5 stars$14.19+4.0%$26.86+89.3%+47.4%$940.86M$43.27M-5.29120Positive NewsFTREFortrea3.2328 of 5 stars$10.07-2.4%$11.50+14.2%-52.3%$937.06M$2.73B-0.8815,500TRVITrevi Therapeutics2.8316 of 5 stars$8.42+10.8%$21.75+158.3%+139.2%$925.50MN/A-20.0520Positive NewsHigh Trading VolumeZBIOZenas BioPharma1.0447 of 5 stars$21.84+1.5%$36.67+67.9%N/A$906M$5M-6.15N/APHATPhathom Pharmaceuticals2.3724 of 5 stars$12.89+3.7%$17.50+35.8%-37.3%$881.83M$55.25M-2.73110News CoveragePositive NewsGERNGeron3.1329 of 5 stars$1.36-0.7%$3.79+178.4%-71.8%$874.08M$76.99M-10.4670Positive NewsIOVAIovance Biotherapeutics4.328 of 5 stars$2.37-0.4%$11.90+402.1%-78.0%$861.21M$164.07M-1.93500 Related Companies and Tools Related Companies uniQure Competitors Sionna Therapeutics Competitors CorMedix Competitors Eyepoint Pharmaceuticals Competitors Fortrea Competitors Trevi Therapeutics Competitors Zenas BioPharma Competitors Phathom Pharmaceuticals Competitors Geron Competitors Iovance Biotherapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:THRD) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersFanatics Hit $31B-Is This Nasdaq Next?Fanatics built an empire by owning the fan experience-scaling to a $31B valuation. But the next wave isn't abo...i2i Marketing Group, LLC | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Third Harmonic Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Third Harmonic Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free THRD Stock Alerts